This edition wraps up FY2026 M&A activity across Australian health and wellbeing and sets out our perspectives for FY2027. It tracks listed-market performance, deal flow and strategic buyer activity across health, wellness, personal care and pharma.
Backed by Edison's cross-border deal experience and proprietary research, it helps founders and boards read valuation trends and position for the year ahead.
Read the full report
This report is available on request. Share a few details and we will email you a personal link to download it.
More in Health, Wellbeing & Pharmaceuticals
Want early access to our next report?
Register your interest and we will share our latest sector insight as it is published.
Access the report
Tell us where to send it and we will email you a personal download link. We will only use your details to share relevant Edison insight.
Check your inbox.
We have emailed a download link to . The link works for 7 days. If it has not arrived in a few minutes, please check your junk folder.
